G.C Chemie Pharmie

What G.C Chemie Pharmie does

G.C. Chemie Pharmie Ltd. (GCCPL) is a privately held Indian pharmaceutical manufacturer founded in 1981 by Gautam Shah and headquartered in Mumbai. The company operates two WHO-GMP certified manufacturing facilities in Vapi, Gujarat — one producing APIs, minerals, and peptides (Eagle Chemical Works, established 1978) and the other producing pharmaceutical excipients under the Novomix brand (Novo Excipients Pvt Ltd, including HPMC, PVP series, and film coating materials). Its product portfolio spans active pharmaceutical ingredients, pharmaceutical intermediates, finished dosage forms (tablets, capsules, injectables), biologics, vaccines, branded formulations, and health supplements and functional foods, exported to over 30 countries across Asia, Africa, Europe, and Latin America.

GCCPL operates a B2B sales-led go-to-market model, functioning as a Contract Development and Manufacturing Organization (CDMO) for global pharmaceutical companies, healthcare brands, and distributors. Revenue is generated across four streams: contract manufacturing and CDMO services, direct API and intermediate sales, finished dosage forms and nutraceuticals production, and export/distribution services. Pricing is quote-based with no public disclosure, and customer acquisition occurs through direct enquiries, industry events (e.g., Vitafoods India 2026), and a content-marketing blog. A recently announced strategic distribution partnership with Aker BioMarine extends GCCPL into the Indian nutraceutical ingredient market with krill oil and algae-based DHA products.

The company pursues regulatory compliance as a core differentiator, with stated alignment to US FDA and EU GMP standards and DCGI approved products, while Eagle Chemical Works is actively expanding facilities to obtain USFDA and EU approvals for higher-value regulated markets. The business is founder-controlled with no disclosed institutional investors, and growth is funded organically.

Name

G.C Chemie Pharmie

Legal name

G.C. Chemie Pharmie Ltd.

Website

https://gccpl.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

51–100 employees

Short description

G.C. Chemie Pharmie is a privately held Indian CDMO and pharmaceutical manufacturer founded in 1981, producing APIs, intermediates, finished dosage forms, biologics, vaccines, and nutraceuticals from two WHO-GMP facilities in Vapi, Gujarat, and exporting to over 30 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

akta.pro secondary industries

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)

Keywords

• Active Pharmaceutical Ingredients
• Contract Manufacturing Services
• Pharmaceutical Intermediates
• Nutraceutical Manufacturing
• Finished Dosage Forms

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Manufacturing & CDMO Services: GCCPL operates as a Contract Development and Manufacturing Organization (CDMO), providing pharmaceutical companies with custom API manufacturing, formulation development, and contract manufacturing services. Revenue is generated through long-term manufacturing partnerships where clients outsource production of APIs, intermediates, and finished dosage forms to GCCPL's facilities.
2. Product Sales - APIs & Intermediates: Direct sale of Active Pharmaceutical Ingredients and pharmaceutical intermediates to pharmaceutical manufacturers globally. The company manufactures and supplies APIs including antibiotics (Amoxicillin), cardiovascular agents, antidiabetics, vitamins (Cyanocobalamin), minerals, and peptides.
3. Finished Dosage Forms & Nutraceuticals: Production and sale of finished pharmaceutical products including tablets, capsules, injectables, syrups, and nutraceuticals. The company also produces health supplements and functional foods for domestic and international markets.
4. Export & Distribution Services: The company exports pharmaceutical products to 30+ countries across Asia, Africa, Europe, and Latin America, providing comprehensive export services including documentation, regulatory compliance support, and logistics coordination.
5. Distribution Partnership Revenue: Through the strategic partnership with Aker BioMarine, GCCPL distributes krill oil and algae-derived DHA ingredients across the Indian market, expanding their nutraceutical distribution business.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

G.C. Chemie Pharmie (GCCPL) is an Indian pharmaceutical, nutraceutical, and functional foods manufacturer that produces and globally supplies Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, finished dosage forms (tablets, capsules, injectables), biologics, vaccines, health supplements, and branded formulations. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering custom API manufacturing, formulation development, and private-label manufacturing services to pharmaceutical companies and healthcare brands across 30+ countries.

Product overview

G.C. Chemie Pharmie (GCCPL) is an innovative Indian pharmaceutical, nutraceutical, and functional foods company with a global presence. The company operates as a comprehensive pharmaceutical manufacturer offering a diversified portfolio of products including Active Pharmaceutical Ingredients (APIs), Pharmaceutical Intermediates, Health Supplements & Functional Foods, Biologics, Vaccines, Finished Dosage Forms (tablets, capsules, injectables), and Branded Formulations. The company also offers contract manufacturing services under CDMO arrangements, including custom API manufacturing, formulation development, and private-label nutraceutical manufacturing. GCCPL serves various therapeutic areas and exports to 30+ countries across Asia, Europe, Africa, and Latin America, with WHO-GMP certified manufacturing facilities in India.

Differentiator

Problem solved

Functional benefit

Brands

• Novomix: Excipients brand offering film coating materials, HPMC, PVP series, and ready-to-use formulations from Indian manufacturing facilities and Novocoat from China.
• Eagle Chemical Works

Products and services

• Active Pharmaceutical Ingredients (APIs) High-quality APIs manufactured under stringent quality standards for use across multiple therapeutic segments globally, including antibiotics, cardiovascular agents, antidiabetics, vitamins, minerals, and peptides, supplied to pharmaceutical manufacturers worldwide.
• Pharmaceutical Intermediates Critical chemical building blocks for complex drug synthesis, produced with precision and consistency to support reliable API and finished formulation manufacturing for pharmaceutical clients.
• Finished Dosage Forms Wide array of tablets, capsules, and injectables manufactured under WHO-GMP conditions to ensure efficacy, stability, and patient compliance, sold to pharmaceutical companies and healthcare brands.
• Branded Formulations Market-specific finished pharmaceutical products designed to combine therapeutic effectiveness with accessibility and affordability for specific regional markets, distributed via B2B channels.
• Health Supplements & Functional Foods Innovative nutraceuticals including vitamins, minerals, herbal supplements, and functional food products formulated to promote wellness, immunity, and preventive healthcare, sold to supplement brands and health product distributors.
• Biologics Advanced biological products including proteins and antibodies developed to support cutting-edge medical treatments and gene therapies, supplied to healthcare organizations and biologics companies.
• Vaccines Safe and effective vaccines aimed at addressing key public health needs across multiple regions, supplied to healthcare organizations and government bodies.
• Novomix Excipients Excipients including readymix film coating materials, HPMC, PVP series under the Novo brand, Novodone and Novocoat products, manufactured by subsidiary Novo Excipients Pvt Ltd and sold to pharmaceutical formulators.
• Contract Development and Manufacturing (CDMO) Services End-to-end contract development and manufacturing services including custom API manufacturing, formulation development, scale-up, technology transfer, process optimization, and regulatory submission support for pharmaceutical companies seeking manufacturing partners.
• Private Label and Third-Party Manufacturing Private label and third-party manufacturing services for health supplements and functional foods, enabling brands to launch products under their own labels using GCCPL's formulation, manufacturing, and packaging capabilities.

Quantifiable outcome

• 43 years of continuous operation serving pharmaceutical and food supplement industry since 1981
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Aker BioMarinecoreChannel Partner/ Reseller/ Distributor · 10 February 2026GCCPL has entered into a strategic distribution partnership with Aker BioMarine to expand distribution of krill oil and algae-derived DHA ingredients across the Indian market. Under this partnership, GCCPL will market Aker BioMarine's Superba Krill oil and Revervia (high-concentration algae-based DHA solution) to pharmaceutical and nutraceutical customers in India. This strategic partnership reflects GCCPL's expansion into the growing Indian nutraceutical market with science-backed, sustainable omega-3 nutrition solutions.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Divi's Laboratories: One of India's largest API and intermediates manufacturers, exporting to global regulated and semi-regulated markets. Highly comparable to GCCPL on API manufacturing focus, GMP-certified facilities, and CDMO contract relationships.
• Granules India: Indian pharmaceutical manufacturer specializing in APIs, pharmaceutical intermediates, and finished dosages (PFIs, tablets, capsules). Overlaps with GCCPL in vertically integrated API-to-FDF manufacturing and global generics distribution.
• Sai Life Sciences: India-headquartered CDMO providing API, intermediate, and formulation services to global innovator and generic pharma. Closely matches GCCPL's full-spectrum CDMO positioning and global customer base.
• Piramal Pharma Solutions: India-based global CDMO offering API manufacturing, formulation development, and biologics services. Direct competitor to GCCPL in the contract development and manufacturing space, with a comparable end-to-end value proposition but greater scale and US FDA-inspected capacity.
• Suven Pharmaceuticals: Indian CDMO focused on API and intermediate manufacturing for global pharma, particularly in CNS and specialty therapeutic areas. Comparable to GCCPL on CDMO business model, export orientation, and GMP-compliant manufacturing.
• Laurus Labs: Indian-headquartered API and CDMO manufacturer with strong presence in APIs, intermediates, and finished dosage forms serving global generic and innovator pharma. Directly comparable to GCCPL on business model, therapeutic coverage, and global export orientation, though materially larger in scale.

Others

• Aker BioMarine: Norwegian biotech producing krill oil and algae-based DHA ingredients for nutraceuticals. Listed as an OTHERS peer given its partnership role as ingredient supplier to GCCPL rather than a manufacturer competitor.

Broad incumbents

• Syngene International: India's largest listed CRO/CDMO, providing contract research, API manufacturing, and biologics services to global pharma. Comparable in CDMO business model and global customer base, with a much larger R&D and biologics footprint than GCCPL.
• Aurobindo Pharma: Large Indian generic manufacturer with extensive API, FDF, and biosimilars portfolio exporting to 150+ countries. Overlaps with GCCPL on APIs, finished dosage forms, and global generics distribution but operates at significantly greater scale and vertical integration.
• Jubilant Pharmova: India-based pharmaceutical and CDMO player offering APIs, dosage forms, and radiopharma. Comparable to GCCPL in CDMO services and finished dosage forms, with broader therapeutic scope and larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gccpl

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about G.C Chemie Pharmie